Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immuncell-LC in Gemcitabine Refractory Advanced Pancreatic Cancer
NCT00965718Phase 2Completed
- Sponsor
- GC Cell
- Start
- Sep 2009
- Primary completion
- Dec 2010
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of immuncell-lc in pancreatic cancer (PC), sponsored by GC Cell. Started Sep 2009; status: completed.
02
Drugs
immuncell-lc
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00965718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00965718.